Prolidase deficiency and systemic lupus erythematosus

Archives of Disease in Childhood

Volumn 76, Issue 5, 1997, Pages 441-444

  Shrinath, M ^a   Walter, J H ^a   Haeney, M ^d   Couriel, J M ^c   Lewis, M A ^b   Herrick, A L ^b  

^a ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^b Department of Nephrology ^*

^c BOOTH HALL CHILDREN S HOSPITAL   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

Author keywords

Prolidase deficiency; Systemic lupus erythematosus

Indexed keywords

PROLINE DIPEPTIDASE;

AMINO ACID METABOLISM; ARTICLE; CASE REPORT; CHILD; ENZYME ASSAY; ENZYME DEFICIENCY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; INBORN ERROR OF METABOLISM; INFANT; MALE; PRIORITY JOURNAL; RISK FACTOR; SEPTICEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TERMINAL DISEASE;

EID: 0030949589     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.76.5.441     Document Type: Article

References (16)

1. Goodman SI, Solomons CG, Muschenheim F, Mclntyre ÇA, Miles B, O'Brien D. A syndrome resembling lathyrism. AmJMed 1968;45:152-9.
2. Phang JM, Yeh GC, Scriver CR. Disorders of proline and hydroxyproline metabolism. In: Scriver CR, Beaudet AL, Sly \VS, Valle D, eds. The metabolic and molecular basis of inherited disease, 7th ed. New York: McGraw Hill, 1995:1125-46.
3. Cleary MA, Haeney M, Couriel JM, Walter JH. Immune function in prolidase deficiency. J Inherit Metab Dis 1994:17:345-8.
4. Bissonnette R, Friedmann D, Giroux JM, et al. Prolidase deficiency: a multisystemic hereditary disorder. J Am Acad Dcrmatol 1993;29:818-21.
5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:I271-7.
6. Myara I, Charpentier C, Lemonnier A. Optimal conditions for prolidase assay by proline colorimetric determination: application to iminodipeptiduria. Clin ChimActa 1982;12S: 193-205.
7. Gooi HC, Chapel HM. Clinical immunology. A practical approach. Oxford: IRL Press, 1990.
8. Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS Suppl I989;6:12-13.
9. .Endo F, Matsuda I. Molecular basis of prolidase (pepndase D) deficiency.MolBioIMed 1991;8:117-27.
10. Milligan A, Graham Brown RA, Burns DA, Anderson I. Prolidase deficiency: a case report and literature review. Br JDermatcl 1989;121:405-9.
11. Arata J, Tada J, Yamada T, Oono T, Yasutomi H, Oka E. Angiopathic pathogenesis of clinical manifestations in prolidase deficiency [letter]. Arch Dermatol 1991;127:124-5.
12. Leoni A, Cetta G, Tenni R, et al. Prolidase deficiency in two siblings with chronic leg ulcérations. Clinical, biochemical, and morphologic aspects. Arch Dermatol 1987;123:493-9.
13. Boumpas DT, Austin HA, Fessier BJ, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatrie, cardiovascular, pulmonary, and hématologie disease. Ann Intern Med 1995;I22:940-50.
14. Johnson AE, Gordon C, Hobbs FOR, Bacon PA. Undiagnosed systemic lupus erythematosus in the country. Lancet 1996;347:367-9.
15. Cervera R, Khamashta MA, Font J, et al. Systemic lupus erythematosus: clinical and immunologie patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine Baltimore 1993;72:113-24.
16. Boumpas DT, Fessier BJ, Austin HA, Balow JE, Klippel JH, Lockshin MD. Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologie and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann Intern Med 1995;123:42-53.